Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Numinus Wellness (NUMI)

Numinus Wellness Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:NUMI
DateTimeSourceHeadlineSymbolCompany
07/10/202211:00PR Newswire (Canada)Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022TSXV:NUMINuminus Wellness Inc
05/10/202211:30PR Newswire (Canada)Numinus Develops Mushroom Tea for Use in Psychedelic ResearchTSXV:NUMINuminus Wellness Inc
29/09/202220:01PR Newswire (Canada)Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022TSXV:NUMINuminus Wellness Inc
22/09/202211:00PR Newswire (Canada)Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiativesTSXV:NUMINuminus Wellness Inc
19/09/202211:00PR Newswire (Canada)Numinus Now Offers Ketamine-Assisted Therapy in TorontoTSXV:NUMINuminus Wellness Inc
13/09/202211:00PR Newswire (Canada)Numinus provides update on acquisition integration and announces new client financing optionsTSXV:NUMINuminus Wellness Inc
31/08/202211:30PR Newswire (Canada)Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022TSXV:NUMINuminus Wellness Inc
14/07/202220:01PR Newswire (Canada)Numinus Wellness Inc. Reports Q3 2022 ResultsTSXV:NUMINuminus Wellness Inc
27/06/202211:00PR Newswire (Canada)Numinus Unveils New Logo and Brand IdentityTSXV:NUMINuminus Wellness Inc
23/06/202211:00PR Newswire (Canada)Numinus Pilots Mental Health Program for Corporate Clients in UtahTSXV:NUMINuminus Wellness Inc
22/06/202211:00PR Newswire (Canada)Numinus Applies for International Patent Filing of Psychedelics Production ProcessTSXV:NUMINuminus Wellness Inc
21/06/202220:05PR Newswire (Canada)Numinus to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022TSXV:NUMINuminus Wellness Inc
10/06/202223:30PR Newswire (Canada)Numinus completes acquisition of Novamind and announces executive appointmentsTSXV:NUMINuminus Wellness Inc
08/06/202220:05PR Newswire (Canada)Numinus announces shareholder approval of resolution in connection with the proposed acquisition of NovamindTSXV:NUMINuminus Wellness Inc
31/05/202211:00PR Newswire (Canada)Numinus announces ISS recommends shareholders vote in favor of the share issuance to acquire NovamindTSXV:NUMINuminus Wellness Inc
11/05/202211:30PR Newswire (Canada)Numinus to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022TSXV:NUMINuminus Wellness Inc
10/05/202211:30PR Newswire (Canada)Numinus Mails Materials for Special Meeting of Shareholders and Announces Interim Court Order for Plan of ArrangementTSXV:NUMINuminus Wellness Inc
09/05/202211:30PR Newswire (Canada)Numinus to Participate in Upcoming Research & Industry ConferencesTSXV:NUMINuminus Wellness Inc
29/04/202212:30PR Newswire (Canada)Numinus Announces the Music as Medicine Event SeriesTSXV:NUMINuminus Wellness Inc
14/04/202220:00PR Newswire (Canada)Numinus Wellness Inc. Reports Q2 2022 ResultsTSXV:NUMINuminus Wellness Inc
12/04/202211:00PR Newswire (Canada)Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and ResearchTSXV:NUMINuminus Wellness Inc
01/04/202211:30PR Newswire (Canada)Numinus to Host Q2 2022 Results Conference Call on April 14, 2022TSXV:NUMINuminus Wellness Inc
30/03/202211:30PR Newswire (Canada)Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPSTSXV:NUMINuminus Wellness Inc
15/03/202211:30PR Newswire (Canada)Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022TSXV:NUMINuminus Wellness Inc
14/03/202211:30PR Newswire (Canada)Numinus Expands Natural Psychedelic Research with New Biosecurity LicenseTSXV:NUMINuminus Wellness Inc
10/02/202212:30PR Newswire (Canada)Numinus to Participate in AAAS 2022 Annual Meeting on February 17-20, 2022TSXV:NUMINuminus Wellness Inc
01/02/202212:30PR Newswire (Canada)Numinus Appoints New Bioscience Advisors to Advance IP DevelopmentTSXV:NUMINuminus Wellness Inc
27/01/202213:30PR Newswire (Canada)Numinus Identified as a Licensed Psilocybin Supplier by Health CanadaTSXV:NUMINuminus Wellness Inc
26/01/202222:15PR Newswire (Canada)Numinus Wellness Inc. Graduates to the OTCQX Best MarketTSXV:NUMINuminus Wellness Inc
20/01/202221:01PR Newswire (Canada)Numinus Wellness Inc. Reports Q1 2022 ResultsTSXV:NUMINuminus Wellness Inc
 Showing the most relevant articles for your search:TSXV:NUMI